『徳島大学 教育・研究者情報データベース (EDB)』---[学外] /
ID: Pass:
  (見出し語句検索:)

登録情報

抽出条件

REF=閲覧 Cancer Medicine (American Cancer Society/Union for International Cancer Control/[日本癌学会])

登録情報の数

有効な情報: 17件 + 無効な情報: 3件 = 全ての情報: 20件

全ての有効な情報 (17件)
  (見出し語句検索:)

条件追加

[種別](著作の種別)による分類 :
[言語](著作の言語)による分類 :
[カテゴリ](著作のカテゴリ)による分類 :
[共著種別](共著の種別)による分類 :
[学究種別](著作の学究種別)による分類 :
[組織](著作の帰属する組織)による分類 :
閲覧 (未定義) …(17)
[年月日](発行年月日)による分類
○ 年による分類 :
○ 年度による分類 :

抽出結果のリスト

排列順: 項目表示:
閲覧 Keiko Yamakawa, Masanao Yokohira, Yuko Narusawa, Sosuke Kishi, Shohei Kanie and Katsumi Imaida : Activation of MEK1/2-ERK1/2 signaling during NNK-induced lung carcinogenesis in female A/J mice., Cancer Medicine, Vol.5, No.5, 903-913, 2016..[誌名] ...
閲覧 Mika K Kaneko, Takuro Nakamura, Ryusuke Honma, Satoshi Ogasawara, Yuki Fujii, Shinji Abe, Michiaki Takagi, Hiroyuki Harada, Hiroyoshi Suzuki, Yasuhiko Nishioka and Yukinari Kato : Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin, using glycan-deficient cell lines generated by CRISPR/Cas9 and TALEN., Cancer Medicine, Vol.6, No.2, 382-396, 2017..[誌名] ...
閲覧 Mika K Kaneko, Shinji Yamada, Takuro Nakamura, Shinji Abe, Yasuhiko Nishioka, Akiko Kunita, Masashi Fukayama, Yuki Fujii, Satoshi Ogasawara and Yukinari Kato : Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity., Cancer Medicine, Vol.6, No.4, 768-777, 2017..[誌名] ...
閲覧 Daichi Shigemizu, Takuji Iwase, Masataka Yoshimoto, Yasuyo Suzuki, Fuyuki Miya, A Keith Boroevich, Toyomasa Katagiri, Hitoshi Zembutsu and Tatsuhiko Tsunoda : The prediction models for postoperative overall survival and disease-free survival in patients with breast cancer., Cancer Medicine, Vol.6, No.7, 1627-1638, 2017..[誌名] ...
閲覧 Kenji Kita, Sachiko Arai, Akihiro Nishiyama, Hirokazu Taniguchi, Koji Fukuda, Rong Wong, Tadaaki Yamada, Shinji Takeuchi, Shoichiro Tange, Atsushi Tajima, Mitsutoshi Nakada, Kazuo Yasumoto, Yoshiharu Motoo, Takashi Murakami and Seiji Yano : In vivo imaging xenograft models for the evaluation of anti brain tumor efficacy of targeted drugs, Cancer Medicine, Vol.6, No.12, 2972-2983, 2017..[誌名] ...
閲覧 Naoto Okada, Takahiro Niimura, Yoshito Zamami, Hirofumi Hamano, Shunsuke Ishida, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Masaki Imanishi and Keisuke Ishizawa : Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database., Cancer Medicine, 2018..[誌名] ...
閲覧 Mitsuhiro Tsuboi, Kazuya Kondo, Kiyoshi Masuda, Shoichiro Tange, Koichiro Kajiura, Tomohiro Kohmoto, Hiromitsu Takizawa, Issei Imoto and Akira Tangoku : Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma, Cancer Medicine, Vol.8, No.9, 4189-4199, 2019..[誌名] ...
閲覧 Hidenori ANDO, M Fukushima, K Eshima, Taichi Hasui, Taro Shimizu, Yu Ishima, C Huang, H Wada and Tatsuhiro Ishida : A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in peritoneally disseminated xenograft model, Cancer Medicine, Vol.8, No.17, 7313-7321, 2019..[誌名] ...
閲覧 (種別) : Yusuke Okuma, Yasushi Goto, Fumiyoshi Ohyanagi, Kuniko Sunami, Yoshiro Nakahara, Satoru Kitazono, Keita Kudo, Yuichi Tambo, Shintaro Kanda, Noriko Yanagitani, Atsushi Horiike, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Makoto Nishio, Yuichiro Ohe and Yukio Hosomi : Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma., Cancer Medicine, Vol.9, No.20, 7418-7427, (発行所), (都市), Aug. 2020..[誌名] ...
閲覧 Kenta Yagi, Marin Mitstui, Yoshito Zamami, Takahiro Niimura, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Masayuki Chuma, Kimiko Fukunaga, Takahiro Shibata, Shunsuke Ishida, Takumi Sakurada, Naoto Okada, Hirofumi Hamano, Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Yanagawa and Keisuke Ishizawa : Investigation of drugs affecting hypertension in bevacizumab-treated patients and examination of the impact on the therapeutic effect., Cancer Medicine, 2020..[誌名] ...
閲覧 Tomohiro Nishimori, Tomonori Higuchi, Yumiko Hashida, Takako Ujihara, Ayuko Taniguchi, Fumiya Ogasawara, Naoya Kitamura, Ichiro Murakami, Kensuke Kojima and Masanori Daibata : Development of a novel cell line-derived xenograft model of primary herpesvirus 8-unrelated effusion large B-cell lymphoma and antitumor activity of birabresib in vitro and in vivo, Cancer Medicine, Vol.10, No.24, 8976-8987, 2021..[誌名] ...
閲覧 Wenhua Shao, Takaaki Tsunematsu, Masaaki Umeda, Hiroaki Tawara, Natsumi Fujiwara, Yasuhiro Mouri, Rieko Arakaki, Naozumi Ishimaru and Yasusei Kudo : Cancer cell-derived novel periostin isoform promotes invasion in head and neck squamous cell carcinoma., Cancer Medicine, (巻), (号), (頁), 2023..[誌名] ...
閲覧 Tetsu Tomonari, Joji Tani, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Tatsuya Taniguchi, Akihiro Morishita, Koichi Okamoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Tsutomu Masaki and Tetsuji Takayama : Initial therapeutic results of atezolizumab plus bevacizumab for unresectable advanced hepatocellular carcinoma and the importance of hepatic functional reserve., Cancer Medicine, Vol.12, No.3, 2646-2657, 2023..[誌名] ...
閲覧 Makoto Takeuchi, Toshihiko Nishisho, Shun-ichi Toki, Shinji Kawaguchi, Shunsuke Tamaki, Takeshi Oya, Yoshihiro Uto, Toyomasa Katagiri and Koichi Sairyo : Blue light induces apoptosis and autophagy by promoting ROS-mediated mitochondrial dysfunction in synovial sarcoma., Cancer Medicine, Vol.12, No.8, 9668-9683, 2023..[誌名] ...
閲覧 Minoru Matsumoto, Takuya Ohmura, Yuto Hanibuchi, Mayuko Shimizu, Yasuyo Saijo, Hirohisa Ogawa, Ryuichiro Miyazawa, Junko Morimoto, Koichi Tsuneyama, Mitsuru Matsumoto and Takeshi Oya : AIRE illuminates the feature of medullary thymic epithelial cells in thymic carcinoma., Cancer Medicine, (巻), (号), (頁), 2023..[誌名] ...
閲覧 Natsuki Teruya, Hiroaki Inoue, Rie Horii, Futoshi Akiyama, Takayuki Ueno, Shinji Ohno and Shunji Takahashi : Intratumoral heterogeneity, treatment response, and survival outcome of ER-positive HER2-positive breast cancer, Cancer Medicine, Vol.12, No.9, 10526-10535, 2023..[誌名] ...
閲覧 Shengjian Jin, Takaaki Tsunematsu, Taigo Horiguchi, Yasuhiro Mouri, Wenhua Shao, Keiko Miyoshi, Hiroko Hagita, Motoharu Sarubo, Natsumi Fujiwara, Qi Guangying, Naozumi Ishimaru and Yasusei Kudo : Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma., Cancer Medicine, 2023..[誌名] ...

過去3日以内に登録・変更された情報

(なし)

本データベースでは情報の登録,保守作業の分散を主たる目的の一つとしております.したがって,上記にリストアップされている情報の保守は個々の情報の当事者に委ねられます.

ある情報を保守する義務があるかないかは,その情報に対して権限を持っているかどうかで判断してください.もちろん情報の所有者が主に管理しなくてはならないことになりますが,権限を持っている利用者が連帯してその情報の保守を行なう義務を負っていると考えてください.

貴方がどの情報について権限を持っているかは,貴方自身の情報を閲覧してください.

Number of session users = 2, LA = 0.27, Max(EID) = 406891, Max(EOID) = 1102736.